Calidi Biotherapeutics

Calidi Biotherapeutics, SPAC, cell therapy, allogeneic, off-the-shelf treatment, Special purpose acquisition company, M&A

Calidi Biotherapeutics goes public through SPAC deal to advance off-the-shelf cancer treatments

Anika Sharma

Calidi Biotherapeutics, a San Diego-based biotech, has chosen the special purpose acquisition company (SPAC) path to enter the public market, ...